Skip to content

Comparision of Two Newer Local Anaesthetics Ropivacaine and Levobupivacaine in Cesarean Section under Spinal Anaesthesia

Efficacy of Ropivacaine Versus Levobupivacaine in Cesarean Section under Spinal Anaesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030719
Enrollment
120
Registered
2021-01-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: ropivacaine versus levobupivacaine: comparision of efficacy of ropivacaine versus levobupivacaine Intervention2: Ropivacaine: Local anaesthetic,10 mg intrathecal for sub arachnoid block

Sponsors

Dr N Sheliya Dainy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: pregnanat women of ae 20 to 40 years ASA grade i and ii gestational age more than 37 weeks

Exclusion criteria

Exclusion criteria: high risk pregnant women kyphosis scoliosis patients allergic to any drugs local site lumbar area infection patients with any systemic diseases

Design outcomes

Primary

MeasureTime frame
ropivacaine is less efficacious than levobupivacaineTimepoint: bloodpressure values are monitored within 1minute,5 minutes and every 15 minutes

Secondary

MeasureTime frame
TO DETERMINE VAS SCORE OF ANALGESIATimepoint: RESCUE ANALGESIA TIMING

Countries

India

Contacts

Public ContactDr Bimal Krushna Panda

VSS institute of medical sciences and research

drbimalpanda@gmail.com9737175425

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026